Inhibikase Therapeutics, Inc. (IKT) Earnings Call Transcript & Summary

Hello, and welcome to the 2025 Annual Meeting of Inhibikase stockholders. Please note that this meeting is being recorded. [Operator Instructions] The meeting is about to begin.

Good afternoon, ladies and gentlemen. My name is Amit Munshi, Chairman of the Board of Directors and Director of Inhibikase Therapeutics, Inc. The Annual Meeting of Stockholders is now called to order. I will now turn the floor over to Mark Iwicki, Chief Executive Officer of Inhibikase. Mark?

Good afternoon, and welcome to the Annual Meeting of Stockholders of Inhibikase Therapeutics, Inc. being held virtually in accordance with our company's bylaws and Delaware law. I'm Mark Iwicki, Chief Executive Officer of the company. I'd like to introduce you to the directors and [ members of management ] who are virtually present with us at the meeting this afternoon. We're pleased to have with us the following directors of the company: Amit Munshi, Chairman; Roberto Bellini; Arvind Kush; Dennis Berman; Vince Aurentz; and Dr. Roy Freeman. We are also pleased to have with us David McIntyre, our Chief Financial Officer; Marishka DeToy of Goodwin Procter, our outside legal counsel, who will record the minutes of the meeting; and Jesse Stoop of CohnReznick LLP, our independent registered public accounting firm. The meeting will please come to order. Jordan Hirsch will serve as the Inspector of Elections for this meeting with authority, among other things, to receive and determine the validity of all proxy and ballots submitted and to certify the number of shares represented at this meeting and the results of the vote of the company's stockholders on any motion. I will now turn the floor over to David McIntyre, our Chief Financial Officer.

Thank you, Mark. Jordan Hirsch has taken and signed an oath to faithfully execute the duties of inspector of elections with strict impartiality and according to the best of his ability. The floor recognizes Jordan Hirsch.

I present the affidavit of Equiniti Trust Company, LLC, the company's mailing and tabulating agent, with respect to the due mailing of the notice of Internet availability of proxy materials to stockholders of the company as well as the due mailing of the notice of the meeting, the proxy statement and the form of proxy to those shareholders requesting it. I also present a list of the holders of the company's common stock as of the close of business on May 1, 2025, the record date for this meeting, as prepared by Equiniti Trust Company, LLC.

The affidavits, proxy materials and list of stockholders are directed to be filed with the records of the company.

The registrar has computed the number of shares represented under the official form of proxy made available or sent to stockholders, to which I have added the number of shares present electronically at this meeting. I report that the holders of at least 61.1 million shares of common stock are represented at the meeting.

A quorum is therefore present, and the meeting is properly constituted for the transaction of business. The proxies and any substitutions of proxies presented to the meeting are hereby ordered filed with the records of the company. Since no stockholder proposals were filed in advance of this meeting, the business of this meeting is limited to the matters contained in the notice of meeting sent on or about May 12, 2025, to all of our stockholders of record at the close of business on May 1, 2025, which are as follows: proposal #1, to elect 2 Class II directors, Amit Munshi and David Canner to the Board of Directors, each to serve until the company's 2028 Annual Meeting of Stockholders and until his successor is duly elected and qualified or until his earlier death, resignation or removal. Proposal #2, to ratify the appointment of CohnReznick LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025. And proposal #3, to approve an amendment to the company's 2020 equity incentive plan to include an automatic evergreen provision and to extend the term of such plan. A vote will now be taken whether to approve the proposals. Once the votes on the proposals have been tallied, the preliminary results with respect to the proposals will be announced. The company will file a Form 8-K with the SEC within 4 business days to announce the exact voting tallies when they become available. If you have sent in a proxy, your vote will be counted automatically without any further action on your part. If you are eligible to vote and have not submitted your proxy or if you want to change your vote, you may do so by clicking the proxy voting site link on the left side of your screen. [Operator Instructions] Please note that in the interest of all shareholders, we will only address those questions that are pertinent to the business of the meeting. It is now at 4:06 p.m. on June 27, 2025, and the polls are open for voting. Will all those who intend to vote electronically at the meeting but not have done so please vote now? [Voting]

I note there are no questions pertinent to the business of the meeting. It is now 4:07 p.m. The polls are now closed with respect to each of the proposals. Jordan Hirsch, would you please report on the votes taken with respect to proposal 1, to elect 2 Class II directors, Amit Munshi and David Canner, to the Board of Directors, each to serve until the company's 2028 Annual Meeting of Stockholders and until his successor is duly elected and qualified or until his earlier death, resignation or removal?

Mr. McIntyre, I would like to advise the meeting that with respect to proposal #1, proposal #2 and proposal #3, Mr. Mark Iwicki and Mr. David McIntyre, as appointed in the official proxy card, have voted in accordance with the proxies received from stockholders. I report that the nominees who received the highest number of affirmative votes of the shares present in person or represented by proxy at the meeting and entitled to vote on the election of directors are Mr. Amit Munshi and Dr. David Canner.

Mr. Amit Munshi and Dr. David Canner have been elected as Class II directors of the company. Jordan Hirsch, would you please report on the vote taken with respect to proposal #2, to ratify the appointment of CohnReznick LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025?

With respect to proposal #2, a majority of the issued and outstanding shares of common stock present in person or represented by proxy at the meeting and entitled to vote on this proposal has been cast in favor of the proposal, and the appointment of CohnReznick LLP is hereby ratified.

Proposal #2 is adopted. Jordan Hirsch, would you please report on the vote taken with respect to proposal #3, to approve an amendment to the company's 2020 equity incentive plan to include an automatic evergreen provision and to extend the term of such plan?

With respect to proposal #3, a majority of the issued and outstanding shares present in person or represented by proxy at the meeting and entitled to vote on this proposal has been cast in favor of the proposal, and the amendment to the company's 2020 equity incentive plan to include an automatic evergreen provision and to extend the term of such plan is hereby approved.

Proposal #3 is adopted. I will now turn the floor over to Mr. Iwicki.

You have now heard the results of the voting, and this completes the business to be conducted at this meeting. Since there are no other matters to come before the meeting, this meeting shall now be adjourned. Thank you for attending, and we appreciate your continued interest in Inhibikase.